Mersana Therapeutics
MRSN
#8913
Rank
S$0.18 B
Marketcap
S$36.95
Share price
0.00%
Change (1 day)
92.31%
Change (1 year)

Earnings for Mersana Therapeutics (MRSN)

Earnings in 2025 (TTM): -S$92.21 Million

According to Mersana Therapeutics's latest financial reports the company's current earnings are S$33.18 Million. In 2024 the company made an earning of -S$87.38 Million, an increase over its 2023 earnings that were of -S$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Mersana Therapeutics from 2016 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$92.21 Million5.52%
2024 -S$87.38 Million-59.94%
2023 -S$0.22 Billion-15.94%
2022 -S$0.26 Billion20.08%
2021 -S$0.22 Billion93.16%
2020 -S$0.12 Billion212.12%
2019 -S$35.84 Million-56.1%
2018 -S$81.65 Million66.02%
2017 -S$49.18 Million182.53%
2016 -S$17.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.19 Billion 111.22%๐Ÿ‡บ๐Ÿ‡ธ USA